You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-specific molecular profile

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial (Letrozole 2.5mg)

Not yet recruiting
  • Endometrial Cancer
  • Letrozole 2.5mg
  • (no location specified)
Jul 26, 2022

Cervical/Supraclavicular Metastasis From Non-small-cell Lung

Recruiting
  • Lung Cancer Metastatic
  • Needle or forceps biopsy of cervical and/or supraclavicular lymph nodes
  • Needle, forceps or surgical biopsy of any lesion other than cervical and/or supraclavicular lymph nodes
  • Roma, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 23, 2023

NSCLC Trial in Washington, Hackensack, Neptune (Nivolumab, Ipilimumab, Carboplatin)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Washington, District of Columbia
  • +2 more
Jan 27, 2023

Cancer Trial in Milwaukee (Targeted agent, Standard of care agent)

Not yet recruiting
  • Cancer
  • Targeted agent
  • Standard of care agent
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 8, 2023

Colorectal Cancer, Resectable Colorectal Carcinoma Trial in Milan (Trastuzumab deruxtecan, Durvalumab, Panitumumab)

Active, not recruiting
  • Colorectal Cancer
  • Resectable Colorectal Carcinoma
  • Trastuzumab deruxtecan
  • +4 more
  • Milan, Lombardia/MI, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
Apr 26, 2023

Hematologic Malignancy Trial in Bologna

Recruiting
  • Hematologic Malignancy
    • Bologna, Italy
      Programma Dipartimentale Terapie Cellulari Avanzate
    Apr 17, 2023

    Molecular Culture for the Diagnosis of Neonatal Sepsis

    Not yet recruiting
    • Neonatal Sepsis, Early-Onset
    • +6 more
    • Molecular Culture
    • (no location specified)
    Feb 28, 2023

    MCW Master Predict

    Recruiting
    • Cancer
      • Milwaukee, Wisconsin
        Froedtert Hospital and the Medical College of Wisconsin
      Apr 6, 2023

      Rheumatoid Arthritis With Late Onset

      Not yet recruiting
      • Rheumatoid Arthritis
      • Salivary sampling
      • Corbeil-Essonnes, France
        Centre Hospitalier Sud Francilien
      Mar 29, 2023

      CNS Tumors, Pediatric Cancer, GEN1 Gene Mutation Trial in Brno, Prague (FoundationOneHeme)

      Recruiting
      • Central Nervous System Neoplasms
      • +3 more
      • FoundationOneHeme
      • Brno, Czechia
      • +1 more
      Apr 23, 2021

      Sarcoma Trial in Rome

      Recruiting
      • Sarcoma
        • Rome, Italy
          "Regina Elena" National Cancer Institute
        Oct 6, 2023

        Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

        Not yet recruiting
        • Minimal Residual Disease
        • Esophageal Squamous Cell Carcinoma
          • Guangzhou, Guangdong, China
            Guangdong Provincial People's Hospital
          Jun 10, 2023

          Staging Endometrial caNcer Based on molEcular ClAssification

          Recruiting
          • Endometrial Cancer
          • +2 more
            • Pamplona, Navarra, Spain
              Clinica Universidad de Navarra
            Jan 30, 2023

            ERA® Test in Patients With Previous Implantation Failures

            Not yet recruiting
            • Infertility of Uterine Origin
            • Implantation Failure
            • Endometrial fluid and biopsy collection
            • Phoenix, Arizona
            • +8 more
            Oct 24, 2023

            Oxidative Stress in Peroperative Analgesia by Intravenous

            Recruiting
            • Oxidative Stress
            • Analgesia
            • Blood sample
            • Tours, France
              University hospital
            Dec 29, 2022

            ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC Trial in Worldwide (PF-06463922, Crizotinib)

            Active, not recruiting
            Has Results
            • ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
            • Fayetteville, Arkansas
            • +71 more
            Feb 16, 2022

            Molecular Signature From Tumor to Lymph Nodes

            Recruiting
            • Lung Cancer
            • +4 more
              • Bordeaux, France
              • +11 more
              Jan 6, 2023

              Evidence Determining Individualized Cancer Therapy for Incurable

              Terminated
              • Hematologic Cancer
              • Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
              • La Jolla, California
                UCSD Moore's Cancer Center
              Jan 31, 2022

              Relevance of Sensitization to Fenugreek in Children

              Not yet recruiting
              • Allergy to Fenugreek
              • Oral Food Challenge
              • Vandœuvre-lès-Nancy, France
                Centre Hospitalo-Universitaire de Nancy
              Apr 15, 2022

              Blood Samples in Patients With Non-small Cell Lung Cancer

              Recruiting
              • Stage III Non-Small Cell Lung Cancer AJCC v7
              • +3 more
              • Biospecimen Collection
              • Laboratory Biomarker Analysis
              • Los Angeles, California
                USC / Norris Comprehensive Cancer Center
              Nov 18, 2022

              Cancer Metastatic Trial in Norway (Atezolizumab)

              Recruiting
              • Cancer Metastatic
              • Bergen, Norway
              • +16 more
              Oct 24, 2022

              Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

              Recruiting
              • Breast Carcinoma
              • +10 more
              • Computed Tomography
              • +4 more
              • Los Angeles, California
                UCLA / Jonsson Comprehensive Cancer Center
              Nov 29, 2022

              Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

              Recruiting
              • Advanced Cancer
              • Solid Tumor
              • Helsinki, Uusimaa, Finland
              • +2 more
              Jun 8, 2022

              NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

              Active, not recruiting
              • Carcinoma, Non-Small-Cell Lung
              • +2 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Aug 24, 2022

              Corresponding to Different Molecular Subtypes of Brest Cancer. A

              Completed
              • Breast Cancer
                • (no location specified)
                Feb 24, 2023